Overview

UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The main goal of this study is to evaluate the effectiveness of the combination of these drugs, and whether they can be given safely together.
Phase:
Phase 3
Details
Lead Sponsor:
University of Arkansas
Treatments:
BB 1101
Bortezomib
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Doxorubicin
Liposomal doxorubicin
Thalidomide